Health Canada is recommending that prescribers not start new patients on diabetes drugs such as Ozempic because of a worldwide shortage, except under certain conditions.
Ozempic, a drug approved to treat Type 2 diabetes, is in short supply in the U.S. after social media and prominent figures popularized the medication as a solution for weight loss.